Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Attacking c-Myc: targeted and combined therapies for cancer.
Oridonin Triggers Chaperon-mediated Proteasomal Degradation of BCR-ABL in Leukemia.
Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S.
